Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Veterinary Medicine

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1774813

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1774813

Equine Healthcare

PUBLISHED:
PAGES: 501 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Equine Healthcare Market to Reach US$10.8 Billion by 2030

The global market for Equine Healthcare estimated at US$7.1 Billion in the year 2024, is expected to reach US$10.8 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Pharmaceuticals segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 11.6% CAGR

The Equine Healthcare market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Equine Healthcare Market - Key Trends & Drivers Summarized

Why Is Equine Healthcare Gaining More Attention?

The equine healthcare market is expanding as horse owners and trainers place greater emphasis on preventive care, advanced diagnostics, and performance optimization. Advances in veterinary medicine, including regenerative therapies, equine vaccines, and diagnostic imaging, are improving horse health and extending their athletic careers. The increasing awareness of zoonotic diseases and equine epidemics is driving demand for vaccinations, deworming treatments, and biosecurity measures.

The use of telemedicine and AI-driven diagnostics is making veterinary care more accessible, allowing for remote monitoring and early disease detection. Genetic testing is also gaining traction in equine breeding programs, helping breeders identify hereditary diseases and optimize selective breeding strategies. As equestrian sports grow in popularity, the need for specialized healthcare solutions tailored to performance horses is driving innovation in the industry.

How Are Technological Innovations Transforming Equine Healthcare?

The adoption of wearable health monitoring devices for horses is revolutionizing equine healthcare. Smart sensors integrated into halters, saddles, and leg wraps can track vital signs, detect signs of lameness, and monitor hydration levels in real-time. AI-powered analytics are helping veterinarians identify health trends, predict potential injuries, and customize treatment plans.

Additionally, regenerative medicine techniques such as stem cell therapy and platelet-rich plasma (PRP) therapy are being used to treat musculoskeletal injuries in performance horses. Advanced diagnostic tools, including MRI and CT scans, are improving the accuracy of lameness detection and internal health assessments. As research in equine medicine continues to progress, the market is expected to witness increased adoption of personalized and data-driven healthcare solutions.

What Are the Key Factors Driving Growth in the Equine Healthcare Market?

The growth in the equine healthcare market is driven by rising equestrian participation, advancements in veterinary technology, and increasing awareness of preventive care. The demand for specialized supplements, performance-enhancing therapies, and diagnostic imaging solutions is growing, particularly among professional horse owners.

The integration of AI, telemedicine, and wearable health monitoring solutions is expanding access to veterinary care and improving disease management. Additionally, regulatory efforts to enforce equine health standards and vaccination programs are boosting market demand. As the equestrian industry continues to evolve, the equine healthcare market is expected to grow significantly, with innovations in diagnostics, treatment, and disease prevention leading the way.

SCOPE OF STUDY:

The report analyzes the Equine Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services, Others); Indication (Musculoskeletal Disorders, Parasitic Infections, Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications); Activity (Sports / Racing, Recreation, Other Activities); Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities, Other Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Arthrex, Inc.
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Covetrus Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Esaote S.p.A.
  • Hallmarq Veterinary Imaging
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Kyoritsu Seiyaku Corporation
  • Merck & Co., Inc. (Merck Animal Health)
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Purina Animal Nutrition LLC
  • Vetoquinol S.A.
  • Virbac
  • W.F. Young, Inc.
  • Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP30816

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Equine Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Equine Ownership and Recreational Horseback Activities Expand Addressable Market Opportunity for Equine Healthcare Solutions
    • Growing Popularity of Equine Sports and Events Spurs Demand for Preventive and Performance-Enhancing Treatments
    • Increasing Focus on Animal Welfare Strengthens Business Case for Advanced Veterinary Diagnostics
    • Surge in Equine Insurance Penetration Drives Adoption of Expensive Therapeutic Interventions
    • Rising Incidence of Equine Infectious Diseases Accelerates Demand for Vaccines and Diagnostic Kits
    • Expansion of Equine Rehabilitation Centers Throws the Spotlight on Specialized Therapeutic Services
    • Increasing Awareness Among Horse Owners Propels Growth of Nutraceuticals and Supplements Market
    • Advancements in Portable Veterinary Imaging Equipment Drive Adoption in Field-Based Equine Healthcare
    • Emergence of Tele-Veterinary Services Enhances Accessibility and Sustains Growth in Rural Equine Markets
    • Integration of AI and Predictive Analytics in Equine Health Monitoring Spurs Innovation and Market Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Equine Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Equine Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Equine Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Equine Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Medicinal Feed Additives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Medicinal Feed Additives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Medicinal Feed Additives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Equine Herpes Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Equine Herpes Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Equine Herpes Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Equine Viral Arteritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Equine Viral Arteritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Equine Viral Arteritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Equine Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Equine Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Equine Influenza by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for West Nile Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for West Nile Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for West Nile Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Tetanus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Tetanus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Tetanus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Musculoskeletal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Musculoskeletal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Musculoskeletal Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Parasitic Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Parasitic Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Parasitic Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Sports / Racing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Sports / Racing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Sports / Racing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Recreation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Recreation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Recreation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Other Activities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Other Activities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Other Activities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: World 15-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for E-commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for E-commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: World 15-Year Perspective for E-commerce by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 65: World Recent Past, Current & Future Analysis for Equestrian Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: World Historic Review for Equestrian Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: World 15-Year Perspective for Equestrian Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 68: World Recent Past, Current & Future Analysis for Other Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: World Historic Review for Other Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: World 15-Year Perspective for Other Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 71: USA Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: USA 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: USA 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 77: USA Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: USA Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: USA 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 80: USA Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: USA Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: USA 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Canada 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Canada 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 89: Canada Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Canada Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Canada 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 92: Canada Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Canada Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Canada 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • JAPAN
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Japan 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Japan 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 101: Japan Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Japan Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Japan 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 104: Japan Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Japan Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Japan 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • CHINA
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 107: China Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: China 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: China 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: China 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 116: China Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: China Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: China 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • EUROPE
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Equine Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Equine Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Europe 15-Year Perspective for Equine Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Europe 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Europe 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Europe 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 131: Europe Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Europe Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Europe 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • FRANCE
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 134: France Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: France 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: France 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: France 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 143: France Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: France Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: France 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • GERMANY
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Germany 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Germany 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Germany 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 155: Germany Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Germany Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Germany 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Italy 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Italy 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Italy 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 167: Italy Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Italy Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Italy 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 170: UK Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: UK 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: UK 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 176: UK Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: UK 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 179: UK Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: UK 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Spain 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 185: Spain Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Spain Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Spain 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 188: Spain Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Spain Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Spain 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 191: Spain Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Spain Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Spain 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 194: Russia Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Russia Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Russia 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 197: Russia Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Russia Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Russia 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 200: Russia Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Russia Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Russia 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 203: Russia Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Russia Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Russia 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Europe Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Europe 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Europe Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Europe 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Europe Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Europe 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 215: Rest of Europe Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Europe Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Europe 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Equine Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 15-Year Perspective for Equine Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Asia-Pacific Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Asia-Pacific 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Asia-Pacific Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Asia-Pacific 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Asia-Pacific Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Asia-Pacific 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 230: Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Asia-Pacific Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Asia-Pacific 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 233: Australia Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Australia Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Australia 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 236: Australia Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Australia Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Australia 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 239: Australia Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Australia Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Australia 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 242: Australia Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Australia Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Australia 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • INDIA
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 245: India Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: India Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: India 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 248: India Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: India Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: India 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 251: India Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: India Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: India 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 254: India Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: India Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: India 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 257: South Korea Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: South Korea Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: South Korea 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 260: South Korea Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: South Korea Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: South Korea 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 263: South Korea Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: South Korea Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: South Korea 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 266: South Korea Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: South Korea Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: South Korea 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Asia-Pacific Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Rest of Asia-Pacific Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Rest of Asia-Pacific 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 275: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Rest of Asia-Pacific Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Rest of Asia-Pacific 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 278: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Rest of Asia-Pacific Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Rest of Asia-Pacific 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 282: Latin America Historic Review for Equine Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Latin America 15-Year Perspective for Equine Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 284: Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Latin America Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Latin America 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 287: Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Latin America Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Latin America 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 290: Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Latin America Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Latin America 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 293: Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Latin America Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Latin America 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 296: Argentina Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Argentina Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Argentina 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 299: Argentina Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Argentina Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Argentina 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 302: Argentina Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Argentina Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Argentina 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 305: Argentina Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Argentina Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Argentina 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 308: Brazil Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Brazil Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Brazil 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 311: Brazil Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Brazil Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Brazil 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 314: Brazil Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Brazil Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Brazil 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 317: Brazil Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Brazil Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Brazil 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 320: Mexico Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Mexico Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Mexico 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 323: Mexico Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Mexico Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Mexico 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 326: Mexico Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Mexico Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Mexico 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 329: Mexico Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Mexico Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Mexico 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Rest of Latin America Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Rest of Latin America 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Rest of Latin America Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Rest of Latin America 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 338: Rest of Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Rest of Latin America Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Rest of Latin America 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 341: Rest of Latin America Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Rest of Latin America Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Rest of Latin America 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 345: Middle East Historic Review for Equine Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Middle East 15-Year Perspective for Equine Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 347: Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Middle East Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Middle East 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 350: Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Middle East Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Middle East 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 353: Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Middle East Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Middle East 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 356: Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Middle East Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Middle East 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 359: Iran Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Iran Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Iran 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 362: Iran Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Iran Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Iran 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 365: Iran Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Iran Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Iran 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 368: Iran Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Iran Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Iran 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 371: Israel Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Israel Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Israel 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 374: Israel Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Israel Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Israel 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 377: Israel Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Israel Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Israel 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 380: Israel Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Israel Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Israel 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Saudi Arabia Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Saudi Arabia 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Saudi Arabia Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Saudi Arabia 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 389: Saudi Arabia Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Saudi Arabia Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Saudi Arabia 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 392: Saudi Arabia Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Saudi Arabia Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Saudi Arabia 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 395: UAE Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: UAE Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: UAE 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 398: UAE Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: UAE Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: UAE 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 401: UAE Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: UAE Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: UAE 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 404: UAE Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: UAE Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: UAE 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Rest of Middle East Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Rest of Middle East 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Rest of Middle East Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 412: Rest of Middle East 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 413: Rest of Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Rest of Middle East Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 415: Rest of Middle East 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 416: Rest of Middle East Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Rest of Middle East Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 418: Rest of Middle East 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030
  • AFRICA
    • Equine Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 419: Africa Recent Past, Current & Future Analysis for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Africa Historic Review for Equine Healthcare by Product Type - Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 421: Africa 15-Year Perspective for Equine Healthcare by Product Type - Percentage Breakdown of Value Sales for Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services and Others for the Years 2015, 2025 & 2030
    • TABLE 422: Africa Recent Past, Current & Future Analysis for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Africa Historic Review for Equine Healthcare by Indication - Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 424: Africa 15-Year Perspective for Equine Healthcare by Indication - Percentage Breakdown of Value Sales for Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications, Musculoskeletal Disorders and Parasitic Infections for the Years 2015, 2025 & 2030
    • TABLE 425: Africa Recent Past, Current & Future Analysis for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Africa Historic Review for Equine Healthcare by Activity - Sports / Racing, Recreation and Other Activities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 427: Africa 15-Year Perspective for Equine Healthcare by Activity - Percentage Breakdown of Value Sales for Sports / Racing, Recreation and Other Activities for the Years 2015, 2025 & 2030
    • TABLE 428: Africa Recent Past, Current & Future Analysis for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 429: Africa Historic Review for Equine Healthcare by Distribution Channel - Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 430: Africa 15-Year Perspective for Equine Healthcare by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities and Other Channels for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!